|
Dear Colleague,
Rapid advancements in technologies and innovative applications towards translational medicine have thrust biomarkers into the forefront of drug discovery and development in recent years. With many leading Pharmaceutical organizations – including Novartis, Hoffmann-La Roche, Pfizer, Bayer, and Bristol Myers Squibb – having fully integrated biomarker strategies in their development processes, it is clear that biomarkers represent the future of medicine. It is projected that throughout the industry, the biomarker market will reach over $12.8 billion dollars by the year 2012. In order to stay abreast of the changing times and truly understand their full potential, we must explore their versatility as well as their limitations.
GTCbio’s 2010 4th Annual Biomarker Discovery and Development Conference (San Francisco, CA Oct. 20-22, 2010) will present you with comprehensive perspectives on the past and present status of biomarker research. By analyzing where we’ve been, we will be able to project into future trends and understand biomarkers’ central role in the paradigm shift in drug discovery & development toward personalized medicine. Starting with an expose of novel technologies to discover biomarkers, we will then focus on how they are utilized to streamline the development process by reducing time and costs and minimize drug attrition associated with safety concerns. Finally, we will highlight their utility in clinical trials and as companion diagnostics in the clinics. Before you and your organization jump into the fray, make sure that you proceed with a strong foundation! GTCbio’s Biomarker Conference Series have consistently delivered the full picture as well as quality environment to share and gain powerful knowledge and insight into cutting edge research. Come join your colleagues in this timely conference and Rediscover Biomarkers!
Registration to this conference will also give you an option of upgrading to unlimited access to the other 3 tracks that are a part of the 6th Modern Drug Discovery & Development Summit and plenary presentations outlined below:
Plenary Session + 4 Tracks
Over 125 leading industrial and academic experts will present at this three-day summit. M3D will offer an in-depth examination of the challenges involved in the dynamic and ever-changing field of drug discovery and development. It will bring researchers, lab directors/managers, and industry executives the critical scientific, technology, and business coverage that they need.
This conference is designed for
- Research & Development Professionals
- Project Managers, Group Leaders and Directors
- Presidents, Vice Presidents, and CEOs
- Manufacturers and Marketers
- Global Project Managers and Strategic Planners
- Business Development and Licensing Executives
- Venture Capitalists and Entrepreneurs
- Academic Researchers and Medical Directors
- Government Representatives
Dedicated networking events have been incorporated to enhance the exchange of information between technology developers and end-users. M3D will provide a great opportunity for companies to expose products and services. Click here to Register for the 6th Modern Drug Discovery & Development Summit or click here to Register for the 4th Biomarker Discovery and Development Conference. Sponsorship and exhibiting opportunities are available in a range of levels, which can be tailored to fit your needs. Please contact 626-256-6405 x 102 or gtcsales@gtcbio.com for more information.
See you in San Francisco,
2010 M3D Organizing Committee
|